Arlington Capital Partners has announced it has agreed to sell Riverpoint Medical to Novanta.
Riverpoint, founded in 2008 and based in Portland, Oregon, designs, develops and markets medical devices for the healthcare and veterinary markets. The company specializes in
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Sells Riverpoint Medical to NovantaIan Gardner and his wife struggled to assemble a holistic care team during her pregnancy. At the end of their journey, they had a son — and a solution they called MilkWise, a one-stop portal where mothers can access
Continue Reading One Portal for Every Perinatal Journey, With Ian GardnerMcGuireWoods partner and host Geoff Cockrell invites colleague Amy Cassalia — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of
Continue Reading Navigating Nuances of Life Sciences Post-Closing, With Amy CassaliaAlbaron Partners has announced the close of its flagship fund.
The fund, Albaron Healthcare Opportunities I, closed with $185 million. It was oversubscribed.
Albaron, founded in 2017 and based in New York, is a lower middle market private equity
Continue Reading Albaron Partners Closes New Fund With $185 MillionThe secondary market has grown to roughly $220 billion as GPs and LPs scramble for liquidity in a private markets cycle stuck in a “worse distribution profile” for three and a half years. Chris Lawrence, managing partner at
Continue Reading GP-Led Secondaries in Lower Middle Market, With Chris LawrenceEir Partners has acquired a controlling interest in QuartzBio, according to a news release.
QuartzBio, founded in 2012 and based in Frederick, Maryland, is a life science technology company that provides connected sample and biomarker intelligence for clinical-stage
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Eir Partners Acquires QuartzBioOncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia, managing director at Cross
Continue Reading Oncology and Retina: Follow the Drug Spend, With Jeanne ProiaHow did Allied Digestive Health build a gastroenterology program that’s “second to none” with roughly 200 gastroenterologists across New York and New Jersey? CEO Matt Devine unpacks the strategies, such as investing in technology and having one EMR across
Continue Reading Building a Gastroenterology Program That’s ‘Second to None,’ With Matt DevineThis special episode is a crossover between The Corner Series and Provident’s Healthcare DealCast released across both McGuireWoods’ and Provident Healthcare Partners’ channels.
McGuireWoods partner Geoff Cockrell is joined by Steve Grassa, director of Provident Healthcare Partners, for
Continue Reading Special Crossover Edition: McGuireWoods Healthcare PE Conference PreviewAvista Healthcare Partners has acquired Bentec Medical from Greyrock Capital Group and Hermitage Equity Partners, according to a news release.
Bentec, founded in 1994 and headquartered in Woodland, California, is a manufacturer of complex, silicone-based medical device components
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires Bentec From Greyrock and Hermitage